SILEXION THERAPEUTICS CORP
SLXN·G1281K130·US·Common Stock·Healthcare - Biotechnology-Activist
SLXN (SILEXION THERAPEUTICS CORP) is held by 3 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($26,785), UBS Group AG ($662), JONES FINANCIAL COMPANIES LLLP ($32). Net institutional sentiment: Mixed.
3
Holders
Avg rating
$27,479
Total Value
50% (3)
Fund Consensus
1 buying - 1 selling
Who's Trading
ActivistMSMoringa Sponsor, LP10.6%Jun 23, 2026
ActivistMSMoringa Sponsor, LP33.0%May 29, 2026
InsiderSMShirvan MitchellSell $31KMar 26, 2026
ActivistMPMitchell P. Kopin9.4%Feb 13, 2026
ActivistLGLind Global Fund III LP6.4%Nov 14, 2025
ActivistMSMoringa Sponsor, LP14.6%Sep 23, 2025
ActivistLALincoln Alternative Strategies LLC6.2%Sep 15, 2025
ActivistOAOrca Capital AG4.9%Sep 15, 2025
ActivistWIWildcat Capital Management, LLC1.3%Jun 26, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer